no appetite tirzepatide reduces appetite, food cravings without increasing dietary restraint How Does Tirzepatide Work for

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist phase 2 trial in type 2 diabetes

doi: 10.1007/s00432-006-0177-6

It works by blocking glucose and sodium reabsorption in the kidneys, promoting their excretion in urine

This is inevitably associated with potential fetal exposure to these drugs

The GLP-1 class of drugs isn't recommended if you have a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia, or a history of pancreatitis

Strategic Considerations for Companies in This Space Businesses that have exposure to GLP-1 compounds should take a careful and realistic look at their operations